Clinical Trials Browser

Phase 4 × pegylated granulocyte colony-stimulating factor × Gynecologic × Clear all

NCT03858166 2024-01-05

Efficacy and Safety of PEG-rhG-CSF Secondary Prophylaxis vs. Therapeutic Administration in Patients With Ovarian Cancer

Phase 4 Terminated

Ovarian Neoplasms

NCT03206684 2017-08-28

To Evaluate the Efficacy and Safety of PEG-rhG-CSF（Jinyouli®） in Reducing Neutropenia in Patients With Cervical Cancer

Phase 4 Unknown

Uterine Cervical Neoplasms